rs138172448
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM1BP4_Moderate
The NM_000070.3(CAPN3):c.1663G>A(p.Val555Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000101 in 1,614,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V555D) has been classified as Uncertain significance.
Frequency
Consequence
NM_000070.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CAPN3 | NM_000070.3 | c.1663G>A | p.Val555Ile | missense_variant | 13/24 | ENST00000397163.8 | |
CAPN3 | NM_024344.2 | c.1663G>A | p.Val555Ile | missense_variant | 13/23 | ||
CAPN3 | NM_173087.2 | c.1519G>A | p.Val507Ile | missense_variant | 12/21 | ||
CAPN3 | NM_173088.2 | c.127G>A | p.Val43Ile | missense_variant | 2/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CAPN3 | ENST00000397163.8 | c.1663G>A | p.Val555Ile | missense_variant | 13/24 | 1 | NM_000070.3 | P2 |
Frequencies
GnomAD3 genomes ? AF: 0.000440 AC: 67AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251418Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135878
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461874Hom.: 0 Cov.: 33 AF XY: 0.0000646 AC XY: 47AN XY: 727238
GnomAD4 genome ? AF: 0.000440 AC: 67AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000416 AC XY: 31AN XY: 74476
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 02, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 13, 2022 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2A Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 28, 2024 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2A;C4748295:Muscular dystrophy, limb-girdle, autosomal dominant 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 16, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at